Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
19.85 USD | +0.27% | 0.00% | +22.18% |
07-03 | Kyowa Kirin Buys Back Shares | MT |
07-02 | Tranche Update on Kyowa Kirin Co., Ltd.'s Equity Buyback Plan announced on February 7, 2024. | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The group's high margin levels account for strong profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Sales forecast by analysts have been recently revised upwards.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- With a 2024 P/E ratio at 25.12 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+22.18% | 10.39B | - | ||
+6.66% | 72.01B | A | ||
+41.28% | 5.26B | B- | ||
-18.53% | 4.64B | A- | ||
+18.24% | 3.7B | - | ||
+27.58% | 2.3B | - | - | |
-39.52% | 1.8B | C- | ||
-45.87% | 1.7B | - | ||
-0.50% | 1.64B | - | - | |
-0.24% | 1.58B | D+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 4151 Stock
- KYKOY Stock
- Ratings Kyowa Kirin Co., Ltd.